Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table (abstract P056) Outcomes by norepinephrine dose at the initiation of net ultrafiltration

From: 44th International Symposium on Intensive Care & Emergency Medicine

Characteristics

All (N = 180)

Low norepinephrine

Net ultrafiltration (n = 138)

High norepinephrine

Net ultrafiltration (n = 42)

p value

Fluid overload at day 14, %, median (IQR)

16.6 [4.8; 34.7]

19.6 [6.4; 36.0]

12.4 [0.5; 30.2]

0.03

Mortality at day 30, n (%)

69 (38.3)

50 (36.2)

19 (45.2)

0.29

Ventilator free days at day 30, median (IQR)

4.5 [0; 22.0]

5.5 [0; 22.0]

0.5 [0; 21.0]

0.24

ICU Length of stay in days, median (IQR)

14.0 [9.0; 23.5]

15.0 [9.0; 24.0]

12.5 [8.0; 23.0]

0.13

Need for RRT at day 90, n (%)

9 (5.1)

7 (5.1)

2 (5.1)

1.00

Ischemic complications during ICU stay

11 (6.1)

7 (5.1)

4 (9.5)

0.29

Mortality at day 30 in patients with SAPSII > 66,

37/90 (41)

26/72 (36.1)

11/18 (61.1)

0.05